Graypoint LLC lessened its holdings in The Allstate Co. (NYSE:ALL – Free Report) by 0.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,834 shares of the insurance provider’s stock after selling 142 shares during the period. Graypoint LLC’s holdings in Allstate were worth $2,813,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC boosted its holdings in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after purchasing an additional 472,040 shares during the last quarter. Raymond James & Associates boosted its stake in Allstate by 10.6% in the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after acquiring an additional 145,986 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Allstate by 3.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock valued at $229,545,000 after purchasing an additional 47,038 shares during the last quarter. Pathway Financial Advisers LLC lifted its position in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after buying an additional 1,047,019 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after purchasing an additional 31,789 shares during the last quarter. 76.47% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have recently weighed in on ALL shares. Roth Mkm reiterated a “buy” rating and issued a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. Raymond James lifted their price objective on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Bank of America boosted their price objective on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Evercore ISI raised their target price on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 9th. Finally, BMO Capital Markets raised their price objective on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $209.50.
Allstate Stock Performance
Shares of NYSE:ALL opened at $188.69 on Thursday. The firm has a fifty day simple moving average of $188.89 and a two-hundred day simple moving average of $175.59. The Allstate Co. has a 52 week low of $127.93 and a 52 week high of $198.79. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $49.97 billion, a P/E ratio of 12.22, a PEG ratio of 1.73 and a beta of 0.48.
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same period last year, the business posted $0.81 earnings per share. The firm’s revenue was up 14.7% compared to the same quarter last year. On average, analysts expect that The Allstate Co. will post 15.23 earnings per share for the current fiscal year.
Insider Transactions at Allstate
In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 192,530 shares of company stock valued at $34,967,665 in the last ninety days. 1.80% of the stock is currently owned by corporate insiders.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- What a Trump Win Looks Like for the Market Now and Into 2025
- There Are Different Types of Stock To Invest In
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Technology Stocks Explained: Here’s What to Know About Tech
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.